Immunicum AB plans to appoint Michael Oredsson as its chairman, pending shareholder approval at its upcoming annual meeting.
The decision was made after Agneta Edberg, the company's current chairman, said she will not stand for re-election.
Oredsson served as CEO of Swedish biotechnology company BioInvent International AB until the end of 2017.
Gothenburg, Sweden-based Immunicum develops therapeutic cancer vaccines.
